OTC : HYPMY

Hypera S.A.

$3.98 USD

-$0.01 (-0.25%)

Volume
180
Average Volume
27.82K
Market Capitalization
$2.8B
P/E Ratio
7.61
Dividend Yield
5.46%
Price Target
Year High
$5.50
Year Low
$3.71
Day High
—
Day Low
—
Payout Ratio
$0.44
Current Ratio
$1.95
Company Overview

OTC

Breno Toledo Pires de Oliveira

Drug Manufacturers - Specialty & Generic

Healthcare

HYPMY

10564

BR

USD

https://www.hypera.com.br

55 11 3627 4206

44914U106

0001486749

Liquidity Metrics

0.62

1.95

1.35

0.67

0.44

Sales & Valuation

$7.7B

1.65

0.91

13.08

1.72

Profitability

$1.89

$1.2B

19.48%

18.50%

13.23%

5.70%

P/E Metrics

7.61

0.07

0.07

Analyst Price Target & Rating

Buy

4/5

1 Analysts

%

Financial Health Scores

1.35

7/9

$3.24B

$29.14B

$15.19B

$2.62B

Key Metrics (TTM)

$20.64B

2.39

7.52

1.95

13.23%

9.21%

13.12%

7.65%

$36.48

250 days

Company Executives
Name Title
Mauricio Christovam Senior Human Resources Officer
Luiz Eduardo Sales Clavis Vice President of Commercial & Marketing
Rafael Vito Batista Chief Operations Officer
Breno Toledo Pires de Oliveira Chief Executive Officer
Hélio Segouras Head of Consumer Health
Ramon Sanches Frutuoso Silva Chief Financial Officer & Investor Relation Officer
Poll Results

No votes yet today — be the first to share your view!

About Hypera S.A. (OTC:HYPMY) Stock

Hypera S.A. is a prominent pharmaceutical enterprise primarily operating within Brazil. The company maintains a diverse product portfolio that includes a vast array of prescription medications, marketed under numerous brand names such as Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid. Beyond prescription drugs, Hypera S.A. also provides dermo-cosmetic solutions, notably through its Mantecorp S ... kincare line. Its consumer health segment features well-known brands including Apracur, Benegrip, Coristina d, Engov, Epocler, and Estomazil, among others. Furthermore, the company offers nutritional and vitamin supplements, with labels such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. Hypera S.A. is also a producer and distributor of a range of similar and generic medicines, including its Neo Química brand, as well as products identified by active ingredients like Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel. Initially known as Hypermarcas S.A., the company officially rebranded to Hypera S.A. in February 2018. Its corporate headquarters are located in São Paulo, Brazil.

Frequently Asked Questions

What is the current Hypera S.A. (HYPMY) stock price?

Hypera S.A.(OTC:HYPMY) stock price is $3.98 in the last trading session. During the trading session, HYPMY stock reached the peak price of $5.5 while $3.71 was the lowest point it dropped to. The percentage change in HYPMY stock occurred in the recent session was --0.25% while the dollar amount for the price change in HYPMY stock was -$0.01.

HYPMY's industry and sector of operation?

The OTC listed HYPMY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of HYPMY?

Mauricio Christovam | Senior Human Resources Officer
Luiz Eduardo Sales Clavis | Vice President of Commercial & Marketing
Rafael Vito Batista | Chief Operations Officer
Breno Toledo Pires de Oliveira | Chief Executive Officer
Hélio Segouras | Head of Consumer Health

How many employees does HYPMY have?

Number of HYPMY employees currently stands at 10564. HYPMY operates from Av. Magalhães de Castro, 4800, São Paulo, SP 05676-120, BR.

Link for HYPMY official website?

Official Website of HYPMY is: https://www.hypera.com.br

How do I contact HYPMY?

HYPMY could be contacted at phone #55 11 3627 4206 and can also be accessed through its website. HYPMY operates from Av. Magalhães de Castro, 4800, São Paulo, SP 05676-120, BR.

How many shares of HYPMY are traded daily?

The average number of HYPMY shares traded daily for last 3 months was 27.82K.

What is the market cap of HYPMY currently?

The market value of HYPMY currently stands at $2.8B with its latest stock price at $3.98